-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Inhibitors of RNAs and RNA Binding Proteins

Program: Scientific Program
Session: JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms
Hematology Disease Topics & Pathways:
Research, Fundamental Science
Sunday, December 8, 2024, 9:30 AM-11:05 AM

Benjamin Cravatt, PhD

The Scripps Research Institute, San Diego, CA

Disclosures: Cravatt: Eisai: Consultancy; Janssen: Consultancy, Research Funding; Pfizer: Research Funding; BMS: Research Funding; Vividion (Bayer): Consultancy, Research Funding.

See more of: JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>